T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services

The State of New Jersey’s Division of Purchase and Property is issuing an RFP (Bid Number 26DPP01283) for the procurement of FDA‑approved Naloxone 4 mg nasal spray (T3165) to be used by the Department of Human Services. Vendors must submit pricing via a state‑supplied price sheet and comply with standard New Jersey procurement terms. The contract period runs from 02 Aug 2027 through 02 Jul 2030 (approximately three years). No bid bond, performance bond, or mandatory pre‑bid conference is required. The solicitation is open and electronic quotes are accepted. • Item: Naloxone 4 mg nasal spray (T3165) – classified under NIGP 269‑72 (Miscellaneous Drugs & Pharmaceuticals) • Quantity: 1 EA (price to be entered on the state‑supplied price sheet) • Contract period: 02/08/2027 – 02/07/2030 (3 years) • Submission deadline: 10/27/2026 2:00 PM (Bid Opening) • No bonds or retainage required; standard state terms apply • Primary contact: Donald Warren, Purchaser, [email protected], (609) 341‑3500